Arkolith/Insider Trading/FULC/Form 4

Tourangeau Greg

Principal Accounting OfficerFulcrum Therapeutics, Inc. (FULC) · full profile →Form 4 · filed May 11, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$695
Net Open-Market Flow
-$695
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 10, 2023Sell(S)210$3.31$69516K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-021245) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML